155 results
6-K
EX-99.1
BLU
Bellus Health Inc
2 Jun 23
Notice of Annual and Special Meeting of Shareholders
4:25pm
to a cease trade order or an order that denied the relevant company access to any exemption under securities legislation that was issued while … company access to any exemption under securities legislation that was issued after the proposed director ceased to be a director, chief executive officer
6-K
EX-99.1
BLU
Bellus Health Inc
19 May 23
Current report (foreign)
5:27pm
Shares are held by my broker, can I still vote in person at the Meeting?
A:
Since the Company may not have access to the names of its non-registered … as proxyholder will not be able to vote at the Meeting. This is because the Company does not have unrestricted access to the names of its non-registered
6-K
EX-99.3
BLU
Bellus Health Inc
19 May 23
Current report (foreign)
5:27pm
, or similar secret access information for their credit card, bank, or other financial accounts. If you receive an unsolicited email claiming to be from
6-K
EX-99.1
BLU
Bellus Health Inc
28 Apr 23
Report of Foreign Private Issuer for the Month of April 2023
3:01pm
proxy related materials directly to NOBO:
Yes
Issuer paying for delivery to OBO:
Yes
Notice and Access (NAA) Requirements:
NAA for Beneficial
6-K
EX-99.1
BLU
Bellus Health Inc
28 Apr 23
Report of Foreign Private Issuer for the Month of April 2023
11:13am
Location (if available) :
Laval, QC
Issuer sending proxy related materials directly to NOBO:
Yes
Issuer paying for delivery to OBO:
Yes
Notice and Access
6-K
EX-99.2
v78khsb8megxsxhp
27 Apr 23
Material Change Report
6:04am
6-K
EX-99.3
qd58zzhu13m5sh5g
27 Apr 23
Material Change Report
6:04am
6-K
EX-99.1
l8tv4uin6yrwd62vub
24 Apr 23
Report of Foreign Private Issuer for the Month of April 2023
7:05pm
6-K
EX-99.1
ctwzo7nwn
18 Apr 23
GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health
6:02am
6-K
EX-99.2
dinsqn6ee 2czon1pdn
30 Mar 23
Notice of Annual and Special Meeting of Shareholders
11:22am
6-K
EX-99.1
j86orzhfa5p8w2
30 Mar 23
Notice of Annual and Special Meeting of Shareholders
11:22am
6-K
EX-99.1
31j8mlhs jjkdjhjas
29 Mar 23
Current report (foreign)
5:26pm
SUPPL
qbcrg4 srmv6
14 Nov 22
Supplemental materials (foreign)
5:25pm
6-K
EX-99.1
gm5r u8ub
14 Nov 22
Open Market Sale Agreementsm
5:19pm
6-K
EX-99.1
fc6ey1293x
16 Sep 22
Investor Presentation NASDAQ/TSX - BLU September 16 th , 2022
4:40pm
F-10
0ywpkdcpbxn ve7mse
26 Aug 22
Registration of securities (Canada)
4:48pm
SUPPL
k8p7wusck
15 Jul 22
Supplemental materials (foreign)
7:01am
6-K
EX-99.2
wy46bw
14 Jul 22
BELLUS Health Announces Pricing of US$153 Million Public Offering in Canada and the United States
4:46pm
SUPPL
nff i8003u
13 Jul 22
Supplemental materials (foreign)
5:01pm
6-K
EX-99.1
lb57wsl k6y272i5a
7 Apr 22
Notice of Annual Meeting of Shareholders
9:01am